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1. Introduction 
Wnt glycolipoproteins are extracellular ligands that can be found in many species, ranging 
from the sea anemone to human [1]. Wnts are signaling factors regulating several key 
developmental processes, such as proliferation, differentiation, asymmetric division, 
patterning and cell fate determination [2,3]. The Wnt family consists of 19 lipid modified 
secreted glycoproteins that are primarily divided into two main categories based on their role 
in cytosolic -catenin stabilization: canonic and non canonic [4,5,6]. During canonical Wnt 
signaling, binding of Wnt ligands to Frizzled/low-density lipoprotein-related protein (LRP) 
receptor complexes causes a stabilization of -catenin, which is normally degraded by 
axin/glycogen synthase kinase-3 (GSK-3)/adenomatous polyposis coli (APC) complexes. 
Stabilized -catenin is then able to translocate to the nucleus and through interactions with the 
T-cell factor (Tcf)/ lymphoid enhancer factor 1 (LEF-1), modulates the expression of specific 
genes [7]. These genes, by regulating cell proliferation, differentiation, adhesion, 
morphogenesis are involved in various essential physiological and physiopathological 
processes as embryonic and adult development, cellular and tissular homeostasis, and diseases 
[8,9,10,11,12]. In contrast, the less-characterized non-canonical Wnt pathways are independent 
of -catenin and transduce Wnt signals through numerous signaling, including either c-Jun 
NH2-terminal kinases (JNK)/planar cell polarity or Wnt/calcium pathways [13,14,15,16,17]. 
During development, Wnts act as morphogens and control the patterning of the embryo by 
triggering concentration-dependent autocrine and paracrine responses [18,19,20]. Globally, 
Wnts are involved in the embryonic myogenesis by regulating the activity of myogenic 
regulatory factors (MRF). 
Whereas data are well established concerning the functions of Wnt proteins during 
embryonic muscle development, the knowledge of the implications of Wnt signaling in 
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adult muscle regeneration and homeostasis is much less advanced. The ability of skeletal 
muscle to grow, maintain, and regenerate itself is dependent on a population of satellite 
cells, a specialized pool of adult myogenic stem cells, that reside in between the muscle 
basal lamina and the cell membrane of myofibers. Satellite cells generate muscle precursor 
cells that then proliferate before they either fuse into an existing myofiber to become post-
mitotic nuclei or fuse together to form myotubes [21,22,23]. Accumulating data show that 
among the signaling proteins, members of the Wnt family are strongly implicated in the 
adult skeletal muscle development, growth and regeneration [24,25,26,27].  
The role of Wnt signaling in myoblast differentiation is supported by the fact that myostatin 
(Mstn), a member of the transforming growth factor- (TGF-) superfamily, negatively 
regulates muscle mass via non-canonical Wnt signaling pathways [28]. Mstn is an important 
regulator of skeletal muscle development and adult homeostasis. Naturally occurring 
mutations, as well as experimental knockout of the Mstn gene, lead to hypermuscular 
phenotype [29,30,31]. Later studies have subsequently established that Mstn regulates the 
size and the number of muscle fibers by inhibiting myoblast proliferation and differentiation 
[32,33,34,35]. In this context, it has been shown that, among the Wnt genes, Wnt4 was the 
most responsive to Mstn, both on differentiation of human bone marrow-derived 
mesenchymal stem cells [36] and on postnatal skeletal muscle growth [28]. Recent studies 
showed that Wnt4 inhibited Mstn expression and Mstn signaling pathway [37]. 
Reciprocally, it has been found that the genetic deletion of Mstn renders the satellite cells 
refractory to the hypertrophic effect of Wnt4, suggesting that the Wnt4-induced decrease of 
Mstn plays a functional role during hypertrophy [37]. Overall, these results indicate that 
Wnt factors are modulator of myogenesis and these actions can be mediated through 
interaction with Mstn. 
In this review, we will detail Wnt signaling pathways, their implications during embryonic 
and adult skeletal myogenesis. A particular attention will be paid to the relation between 
Wnt factors, particularly Wnt4 and myostatin. 
2. Wnt signaling 
2.1. Components of the Wnt signaling pathway 
2.1.1. Wnts, the ligands 
Wnt proteins constitute a large family of cystein-rich secreted glycolipoproteins that control 
development in organisms ranging from nematode worms to mammals [38]. To date, at 
least 19 Wnt genes have been identified in mammals; they are similar in size, ranging from 
39 kDa to 46 kDa [39,40,41]. All Wnts have a signal sequence followed by a highly conserved 
distribution of cysteine residues, the spacing of which is highly conserved, suggesting that 
Wnt protein folding may depend on the formation of multiple intra-molecular disulfide 
bonds [42,43]. Once secreted, Wnt ligands remain tightly associated with the extracellular 
matrix, with a strong affinity for heparin sulfate proteoglycans [44,45]. In addition, Wnt 
ligands are carried on lipoprotein particles to facilitate signaling activities in the intercellular 
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space [46,47,48]. Although Wnts are secreted proteins, they are highly insoluble and have 
therefore been difficult to be purified [39,49]. As a consequence, very little is known about 
the structure and biochemical properties of Wnt proteins. They mediate their signaling 
activity through the interaction with the seven transmembrane Frizzled (Fzd) receptor and 
the co-receptor LDL-receptor related protein (LRP) [50,51,52]. The Wnt family members can 
be divided in two distinct classes depending on their ability to induce transformation of the 
mouse mammary epithelial cell line C57MG [53]. The highly transforming members include 
Wnt1, Wnt3, Wnt3a, and Wnt7a. The intermediately transforming or non-transforming 
members include Wnt2, Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7b, and Wnt11 [54]. These two 
groups of Wnts signal via intracellular pathways that trigger different developmental 
outcomes [53]. In mammals, highly transforming Wnts have been associated to the canonical 
Wnt/β-catenin pathway, whereas non-transforming Wnts have been associated activate to 
the non-canonical pathway [4,6]. It is noteworthy that this binary classification is becoming 
obsolete, thus although Wnt4 was originally described as a non-canonical Wnt (non-
transforming Wnt), it has also been implicated in the activation or inhibition of the canonical 
Wnt pathway [55,56,57,58,59,60,61]. Wnt7a has also been implicated in both canonical and 
non-canonical Wnt signaling depending on the cell and tissue context [62,63]. Non-canonical 
Wnt signaling pathways are less well defined, but appear to function in a β-catenin 
independent manner to regulate processes such as convergent extension during vertebrate 
gastrulation, and planar polarity [64,65,66,67,68].  
2.1.2. Frizzled, the receptors 
Frizzled genes encode membrane proteins that mediate multiple signal transduction 
pathways. They have been identified in diverse animals, from sponges to humans. These 
proteins belong to the family of G protein-coupled receptor proteins which act as receptors 
for secreted Wnts [51,69,70]. Ten frizzled proteins have been identified in mouse and 
humans, and all share the following structural similarities: a signal peptide sequence at the 
amino terminus, a conserved region of 120 amino acids in the extracellular domain 
containing 10 invariantly spaced cysteines (called the cysteine rich domain CRD), a seven-
pass transmembrane region, in which the transmembrane segments are well conserved, and 
a cytoplasmic domain with little homology among members of the family [71,72,73,74]. The 
structure of CRD domain has been solved and it appears to be necessary and sufficient for 
binding to Wnt [74,75]. Fzds are coupled with trimeric G proteins, and the Wnt stimulated 
pathway is sensitive to inactivation by pertussis toxin. Specificity of the Wnt-Fzd interaction 
remains largely unknown, particularly in vertebrates, because of the large numbers of Wnts 
and Fzds [76,77,78]. 
2.1.3. LRPs, the co-receptors 
Low-density receptor-related protein 5 and 6 (LRP-5 and LRP-6), which are highly 
homologous, are members of the low-density-lipoprotein (LDL) family of receptors [79,80]. 
LRP functions as a co-receptor for Wnt signaling leading to the activation of the Wnt/β-
catenin pathway. LRP-5 and LRP-6 are type I single-span transmembrane proteins 
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[81,82,83]. LRP-5 and -6, which bind to Axin through their intracellular domain, are key 
signaling receptors for the β-catenin pathway [84,85]. The binding between LRP5 and LRP6 
is directly associated to the stabilization of β-catenin [79]. 
2.1.4. Secreted modulators of the Wnt pathway 
The extracellular antagonists of the Wnt signaling pathway can be divided into two broad 
classes. The first class, which includes the secreted Frizzled receptor (sFRP), primarily binds 
to Wnt proteins; the second class comprises the Dickkopf (Dkk) family, which binds to the 
LRP subunit of the Wnt receptor complex [86,87,88]. Both classes of molecules prevent 
ligand-receptor interactions by different mechanisms [89]. sFRPs share homology in the N-
terminal region with the cysteine-rich domain of Frizzled proteins, but lack the 
transmembrane domain [90,91]. sFRPs inhibit Wnt signaling by competing with Fzd for Wnt 
ligands or in a dominant negative fashion by forming a non-signaling complex with Wnt 
[92]. There are presently five known members of the family in mouse, sFRP1 to sFRP5. 
sFRPs are composed of a cysteine rich domain (CRD) and a domain that shares weak 
sequence similarity with the axon guidance protein netrin (NTR) in the C-terminus [93,94]. 
The CRD shares 30-50% sequence similarity with those of Fzd proteins and includes 10 
conserved cysteine residues. 
The four members of the Dickkopf (Dkk) family (Dkk-1 to Dkk-4), inhibit Wnt signaling by 
binding to the LRP-5 and LRP-6 components of the receptor complex [87,95]. Dkks contain 
two characteristic cysteine-rich domains (Cys-1 and Cys-2) separated by a linker region of 
variable length. Cys-2, in particular, is highly conserved among all 69 members of the family 
and contains 10 conserved cysteine residues [88,89]. 
2.1.5. Dishevelled 
Dishevelled (Dvl) is a phosphoprotein essential for the transduction of the Wnt signaling 
pathway. The Dvl family comprises three Dvl proteins (Dvl-1, Dvl-2, and Dvl-3). The 
structure of Dvl family members consist of three highly conserved domains: an amino-
terminal DIX domain, a central PDZ domain, and a carboxy DEP domain [96]. Dvl act as a 
key transducer of the Wnt signal and act at the plasma membrane or in the cytoplasm. Dvl is 
differentially targeted to participate in either Wnt/β-catenin or PCP signaling [6,7,97]. 
Activation of a specific pathway through Dvl depends on its subcellular localization and 
activation of modulator downstream. In Wnt/β-catenin pathway, once Wnt binds to the Fzd 
transmembrane receptor and the co-receptor LRP5/6, Dvl can interact with the Fzd/LRP 
complex. Dvl is phosphorylated by casein kinase Iε to form a complex with Frat1 and 
inhibits GSK3β activity, leading to stabilization of cytoplasmic β-catenin. 
The Planar cell polarity pathway makes use of Dvl to modify the actin cytoskeleton [98,99]. 
At the level of Dvl, an independent and parallel pathway leads to the activation of the small 
GTPases Rho [66]. Rho signaling occurs through the molecule Dishevelled associated 
activator of morphogenesis 1 (DAAM1) [66]. The Rho pathway leads to the activation of Rho 
associated kinase, which mediates cytoskeletal reorganization [6,99]. 
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2.2. The canonical or Wnt/-catenin pathway 
Wnt family glycoproteins are primarily divided into two main categories based on their role 
in cytosolic β-catenin stabilization: canonic and non-canonical [4,5,6,100] (Figure 1). Signaling 
through the Wnt/β-catenin pathway also called canonical pathway, modify the stabilization 
of β-catenin. In the absence of Wnt binding to Frizzled receptors, β-catenin is targeted for 
degradation by a multi-protein destruction complex composed of the tumor suppressor 
protein APC (adenomatous polyposis coli gene product), axin, and glycogen synthase kinase 3β 
(GSK3β) [101,102]. This process is triggered by phosphorylation of β-catenin by the 
serine/threonine kinases, GSK3β and Casein Kinase [103]. In the complex, the interaction 
between these kinases and β-catenin is made easier by the scaffolding proteins Axin and APC 
[104,105,106,107]. Phosphorylated β-catenin is recognized by β-transducin repeat containing 
protein (β-TrCP), targeted for ubiquitination, and degraded by the 26S proteasome [108,109]. 
Binding of Wnts to its receptors Frizzled and its co-receptor LRP5/6, inhibits the kinase 
activity of the destruction complex, and leads to the stabilization of non-phosphorylated β-
catenin [110,111]. This mechanism involves either the recruitment of Axin to the plasma 
membrane after the phosphorylation of LRP5/6, or the action of an axin-binding molecule, 
Dishevelled (Dvl) [96,112]. Kinase inhibition leads to the accumulation of free cytosolic β-
catenin. The elevated cytosolic β-catenin can translocate to the nucleus, where it interacts 
with the N-terminus of the DNA-binding proteins of the T-cell factor/Lymphoid enhanced 
factor (Tcf/Lef) family [113,114,115]. This transient interaction with β-catenin converts Tcf/Lef 
factors into transcriptional activators. In the absence of Wnt, Tcf/Lef proteins repress target 
genes through a direct association with co-repressors such as Groucho [102,116,117]. 
2.3. Non-canonical signaling pathways 
In contrast, non-canonical Wnts transduce their signal independently of β-catenin. The non-
canonical Wnt signaling pathway has been found to be associated with gastrulation 
movements, heart induction, dorsoventral patterning, tissue separation and neuronal 
migration [6]. Unlike the canonical Wnt signaling pathway, the non-canonical Wnt signaling 
pathway is quite diverse. Thus, it has been reported that non-canonical Wnts can activate 
calcium flux, G proteins, Rho GTPases, or c-Jun N-terminal kinase (JNK) [6,66,82]. 
The response to a given stimulus depends not only on which Wnt is present, but also on 
which cognate receptor is expressed on the cell [118], It is likely that one Wnt protein can 
signal more than one type of response in a cell if multiple types of receptors are present [58]. 
Adding still more layers of complexity, cofactors, secreted antagonists and co-receptors of 
Wnt signalling are likely to affect both canonical and non-canonical actions [89,119]. 
2.3.1. Calcium pathway 
Activation of this signaling pathway involves Wnt binding to a Frizzled receptor, subsequent 
release of intracellular calcium associated with the activation of various enzymes such as 
Ca2+/calmodulin-dependent (CamKII) protein kinase and Protein Kinase C (PKC) [6,120,121,122] 
(Figure 1). Here, frizzled receptors act through G-protein and activate phospholipase C (PLC)  
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From Franco et al. Current Opinion in Genetics & Development 2009, 19:476–483 
Figure 1. Three Wnt-dependent pathways have been proposed: (a) canonical Wnt/β-catenin pathway 
and (b and c) non-canonical Wnt/PCP and Wnt/Ca2+ pathways. Canonical and non-canonical pathways 
possess clear different signaling events; however, the distinction between Wnt/PCP and Wnt/Ca2+ 
pathways is less obvious and common events occur on those pathways. (Dashed lines illustrate the idea 
that no clear boundaries exist between the different Wnt pathways.) (a) Canonical Wnt/β-catenin 
pathway. In cells, β-catenin is normally associated with adherens junctions and can also be free in 
cytoplasm. In cells non-stimulated by Wnt ligands (which can additionally be inhibited by WIF, sFRPs 
and Dkk protein family members) cytosolic β-catenin is targeted to proteolytic degradation through 
phosphorylation by the APC–Axin–GSK3 β–CK1γ complex and further ubiquitination through action 
of βTrCP-dependent E3 ubiquitin ligase complex. On stimulation by Wnt ligands though binding to Fzd 
receptors and its co-receptors Lrp5/6, Fzd recruits Dvl. Dvl will inhibit APC–Axin–GSK3β–CK1γ 
complex formation by the recruitment and inhibition of GSK3β, CK1γ and Axin to the cytoplasmic 
membrane. Consequently, β-catenin can accumulate in the cytoplasm and enter the nucleus, activating 
transcription of target genes through association with Lef1/TCF transcription factor family. (b) Non-
canonical Wnt/Ca2+ pathway. Interaction of Wnt ligands with Fzd receptors can lead to an increase in 
intracellular calcium level, through possibly the activation of PLC. Intracellular calcium will 
subsequently activate CAMKII and PKC in cells, as well as the transcription factor NFAT. This pathway 
is particularly important for convergent-extension movements during gastrulation. Additionally, Fzd 
receptors in association with Kny, Ror2 or Ryk receptors can also activate JNK promoting expression of 
specific genes through activation of AP-1. (c) Non-canonical Wnt/PCP pathway. This pathway is 
characterized by an asymmetric distribution of Fzd, CELSR, Pk and VANGL2, resulting in the 
polarization of the cell. Also, Wnt-signaling activates Rho GTPases Cdc42, RhoA and Rac1 leading to 
cytoskeleton rearrangement, with the participation of Daam1. Rac1 can also activate JNK, activation-
specific gene transcription through modulation of AP-1 protein complex. 
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and phosphodiesterase (PDE), which lead to increased concentrations of free intracellular 
calcium and to decreased cyclic guanosine monophosphate (cGMP) [121,123,124]. Elevated 
free intracellular calcium can activate the phosphatases calcineurin, leading to 
dephosphorylation and activation of the transcription factor NFAT [14]. 
2.3.2. Planar cell polarity pathway 
The planar cell polarity (PCP) pathway regulates the orientation and migration of polarized 
cells during development and defects underlie severe abnormalities [66,67,125]. Although, 
the regulation of this pathway appears to be incredibly complex, in vertebrates, it signals 
mainly through the JNK pathway. Upon binding of Wnt to its receptor Frizzled, there is 
activation of Disheveled, JNK and Rho family GTPases, which direct asymmetric 
cytoskeletal organization and coordinated polarization of cells within the plane of epithelial 
sheets [68,126,127] (Figure 1). 
3. Implication of Wnt signaling in skeletal myogenesis 
3.1. Embryonic skeletal myogenesis 
Like any process of tissue development, skeletal muscle development is under the control of 
two regulation pathways: an intrinsic pathway implicating transcription factors (Pax3, Pax7, 
Myf5, MyoD1, Mrf4, Myogenin, Six proteins, SRF….) and an extrinsic pathway implicating 
external factors as Wnt, sFRP, Myostatin, Sonic Hedgehog (Shh), BMP, Notch, FGF, 
HGF/Met, insulin, IGF1, retinoic acid…. 
3.1.1. Intrinsic pathway 
Muscles of the trunk and limbs of vertebrate embryos are derived from somites. These 
segmental masses correspond to a series of transient repeated epithelial structures that 
derive from the paraxial mesoderm and lie on either side of the neural tube [128]. Somites 
eventually differentiate into five major cell types: cartilage, bone, and tendons of the trunk, 
skeletal muscles of the body and the dermis of the back [128,129,130,131]. This process is 
regulated by sonic hedgehog (Shh) and Wnt signals that are secreted by tissues surrounding 
the somites [132,133]. This process leads to patterning of the epithelial structures into 
distinct compartments that give rise to diverse cell lineages [129,131,133,134]. The 
compartments formed are (i) the mesenchymal sclerotome which contributes to cartilage 
and bone of the vertebral column and ribs and (ii) the dorsally located epithelial 
dermomyotome where myogenic precursors are localized and ultimately give rise to epaxial 
(back) and hypaxial (muscles of the ventral body wall, limbs, diaphragm and tongue) 
muscles [134,135]. All cells of the dermomyotome, including the epaxial and hypaxial zones, 
are initially positive for the Pax3 transcription factor, whereas Pax3/Pax7 double positive 
cells are only located in the central domain [136]. Myogenesis is initiated by the 
translocation of myogenic progenitors that migrate as Pax3 positive cells from the 
extremities of the dermomyotome to the myotomal layer below or as Pax3/7 double positive 
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cells from the central dermomyotome to the myotome [128,133,137,138,139,140,141]. These 
cells enter the myogenic program after activating of the myogenic regulatory factors (MRFs): 
Myf5 and Mrf4 [2,142]. Double mutant Pax3/Pax7 mouse embryos suffer from a major 
skeletal muscle deficit where only the early myotome is formed, but the cells in these 
structures do not activate Myf5 or MyoD and consequently fail to enter the myogenic 
program consequently, they die or migrate towards a non myogenic fate [143,144]. Pax3 and 
Myf5/Mrf4 control the activation of MyoD, another MRF family member and MyoD positive 
myogenic precursors differentiate into myofibers or remain as a proliferating population 
called satellite cell population [145,146].  
3.1.2. Extrinsic pathway 
Numerous environmental paracrine factors are associated to the regulation of skeletal 
myogenesis, thus, for example, Notch signaling plays a role in cell fate determination in the 
lateral dermomyotome [147], in the amplification of Pax3+/Pax7+ progenitors cells and in the 
myoblastic proliferation [148].  
Overall, Wnt protein family has been determined along with Shh to be the main molecules 
required to activate myogenesis [149,150,151,152] (Figure 2). 
In response to Shh and Wnt signals from the notochord and neural tube, somites delaminate 
to form the sclerotome and dermomyotome. The notochord and the floor plate of the neural 
tube secrete ventralizing signals, including Shh whereas the surface ectoderm and the dorsal 
neural tube secrete Wnt proteins [153]. These two morphogens will induce the induction of 
MRFs leading to the delamination, specification and myoblast differentiation. 
In a remarkable study realized from chicken cultures of presomitic mesoderm cells, A.E 
Munsterber et al. have shown that Wnts could mimic the inducer effect of the dorsal neural 
tube and that Shh could mimic the effect of the floor plate and the notochord [25,154]. These 
results indicated that Wnt1, Wnt3, Wnt4 and Shh could replace the inducer role of the dorsal 
neural tube and the floor plate/Notochord structures. Ectopically implanted Wnt1, Wnt3a 
and Wnt4 expressing cells in chicken alter the process of somite compartmentalization in 
vivo, resulting in an enhanced recruitment of somitic cells into the myogenic lineage [155]. In 
the same study, authors reported no difference on somite development between neural tube 
(expressing Wnt1 and 3a) and surface ectoderm (expressing Wnt4), suggesting that surface 
ectoderm promote myogenesis by Wnt4 secretion [155]. 
In mouse, similar experiments indicated that the expression of Myf5 is induced by a signal 
emanating from neural tube and that the expression of MyoD is depending of a signal 
coming from surface ectoderm [156]. Wnt7a secreted by the surface ectoderm and 
Wnt1/Wnt3a secreted by dorsal neural tube regulate MyoD and Myf5 expression, 
respectively whereas Wnt4 and Wnt5a regulate both MyoD and Myf5 expression [132]. 
Furthermore, it has been shown that Wnt1, Wnt3a and Wnt4 are expressed in the dorsal half 
of the neural tube when epaxial myogenesis is initiated [153]. Regulation of hypaxial muscle 
specification is less understood but Tajbakhsh et al, 1998 have shown that Wnt7a and to a 
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lesser extent Wnt4 and Wnt5a can activate myogenesis in mouse paraxial mesoderm 
explants [132]. Conversely, sFRPs, inhibitor of Wnt signaling, markedly reduce myogenesis 
by antagonizing Wnts [157,158].  
Use of somites from transgenic mice expressing lacZ reporter gene under the control of 
Myf5 epaxial promoter in presence of a constitutive form of -catenin or in presence of the 
neural tube lead to a strong activation of the reporter, indicating that the Wnts secreted by 
the neural tube act mainly through canonical pathway [159]. In the surface ectoderm, 
signaling pathway initiated by Wnt7a differs from that by Wnt1. Wnt7a binds to Frz7 and 
signals through Protein kinase C, a β-catenin independent pathway [122,149]. Recently, the 
Wnt PCP pathway has been implicated in regulating the orientation of myocyte growth in 
the developing myotome [160]. As reported during osteogenic differentiation or during 
recruitment, maintenance, and differentiation of human bone marrow mesenchymal stem 
cells a cross-talk between canonical and non-canonical Wnt signaling exists and may lead to 
functional antagonism [161,162]. 
In chick embryos, Nohno's group analyzed the myogenic effects of Wnt4 overexpression in 
the limb bud in order to evaluate the significance of this factor in skeletal muscle formation 
during embryogenesis. They found that Wnt4 treatment induced an increase in the muscle 
mass, particularly in fast-type muscle size. Furthermore, ectopic Wnt4 induces muscle 
satellite markers Pax7 and MyoD expression [60]. 
As extrinsic factors, myostatin (Mstn), a member of the TGF- superfamily, has been 
proposed as a regulator of embryonic myogenesis [30,32,34,163,164,165,166]. Myostatin, also 
called GDF8 (growth differentiation factor 8), is a secreted growth factor that belongs to the 
transforming growth factor- (TGF-) superfamily of growth and differentiation factors [30]. 
In mice, myostatin is predominantly expressed in skeletal muscle tissues from the period of 
embryogenesis to adulthood suggesting a role for this factor in the control of muscle 
development and function [30,166]. The role of myostatin in muscle comes from the 
phenotype of myostatin-deficient animals. Myostatin was first found to regulate muscle 
mass in mice from which the gene encoding myostatin has been knocked-out. The resulting 
“mighty mice” displayed muscle overgrowth due to both hyperplasia (increased number of 
muscle fibers) and hypertrophy (increased size of individual muscle fibers). These effects on 
muscle mass are persistent throughout the life of the animals. The phenotype of these mice 
suggested that myostatin functions as a negative regulator of muscle growth. Interestingly, 
the function of myostatin appears to have been conserved across diverse species. Natural 
mutations in the myostatin gene have been identified in double-muscled animals such as the 
Belgian blue cattle [29,167,168]. The recent identification of a hypermuscular child with a 
loss-of-function mutation in the myostatin gene suggests that the function of myostatin is 
similarly conserved in humans [169]. In support of this, myostatin sequence has been highly 
conserved through evolution, among species ranging from zebrafish to humans [30]. At 
early embryonic stages, myostatin expression is restricted to the myotome compartment of 
the developing somites, and myostatin has been proposed to play an essential role in 
skeletal muscle growth and development [30,165].  
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It is of note that many others autocrine or paracrine factors, such as Notch, Tgf-, Bmp, 
Noggin, mi-RNA…, play a subtle but crucial role in orchestrating the regulation of 
embryonic myogenesis [170,171,172,173,174,175,176]. Undoubtedly, the complete decoding 
of this intricate network will take several years to be complete.  
 
From Bentzinger et al. Cold Spring Harb Perspect Biol 2012 
Figure 2. Embryonic myogenesis. Illustration of the morphogen gradients along the rostral–caudal axis 
of the embryo. (C) Schematic of transverse sections through the embryo at early (i) and late (ii) stages of 
somitogenesis. (Ci) Morphogens secreted from various domains in the embryo specify the early somite to 
form the sclerotome (SC) and dermomyotome (DM). Wnts secreted from the dorsal neural tube (NT) and 
surface ectoderm (SE) along with bone morphogenetic protein (BMP) from the lateral plate mesoderm 
maintain the undifferentiated state of the somite, whereas Sonic hedgehog (Shh) signals from the neural 
tube floor plate and notochord (NC) induce the formation of the sclerotome. (Cii) As the sclerotome 
segregates, muscle progenitor cells (MPCs) from the dorsomedial (DML) and ventrolateral (VLL) lips of 
the dermomyotome mature give rise to the myotome (MY). At the level of the limb bud, Pax3-dependent 
migrating MPCs delaminate from the ventrolateral lips to later give rise to limb muscles. 
3.2. Postnatal myogenesis 
3.2.1. Satellite cells 
The main role of satellite cells during the early postnatal period is to provide myonuclei for 
skeletal muscle growth. They contribute to the postnatal growth of syncital muscle cells, 
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which in adults contain approximately 6–8 times more nuclei than in neonates [177]. In adult 
muscle, satellite cells are mitotically quiescent and do not express myogenic regulatory 
factors (MRFs) [178,179]. Their role changes to one of providing myonuclei for homeostasis 
and hypertrophy or in response to the more sporadic demands for myofiber repair and 
regeneration [180]. In the latter context, satellite cell activation is dramatically enhanced; they 
reenter the cell cycle and proliferate [181,182], at this stage they are often referred to as either 
myogenic precursor cells or myoblasts [182,183]. Some resulting myoblasts differentiate and 
fuse to form replacement myofibers, whereas some remain as continual dividing cells to 
replenish the pool of satellite cells in anticipation of future rounds of regeneration [182,184]. 
Pax7 is expressed in quiescent as well as activated satellite cells, and it is down regulated 
when satellite cells commit to muscle differentiation [177,185,186]. Compared to embryonic 
satellite cells, quiescent adult satellite cells do not require Pax7 for self-renewal and 
regeneration [187]. The progression of activated satellite cells toward myogenic 
differentiation is mainly controlled by Myf5 and MyoD [188] and is followed by fusion into 
regenerating fibers. Satellite cells undergo different fates, giving rise to a few Pax7+MyoD– 
cells, which return to quiescence (satellite stem cell population), and many Pax7+MyoD+ 
cells, which differentiate [189]. These asymmetric divisions are mainly regulated by Notch 
signaling [190,191,192]. In addition, satellite stem cells which represent approximately 10% 
of Pax7+ mouse satellite can undergo planar symmetric cell divisions to drive expansion of 
their population [190]. By a subtractive hybridization approach, Legrand et al. found that 
Wnt7a is expressed during muscle regeneration and acts through Fzd7 receptor to induce 
symmetric satellite stem cell expansion and thus enhance muscle regeneration. Wnt7a 
signaling though Frz7 receptor requires association with Vangl2, a membrane protein 
involved in the regulation of PCP suggesting that Wnt7a utilizes this non-canonical pathway 
to control the orientation of satellite cell division [62]. They suggest that Wnt7a regulates the 
homeostatic maintenance of the satellite stem cell pool by modulating the increase in 
satellite stem cell expansion during regenerative myogenesis and that basal levels of PCP 
signaling are insufficient to maintain the satellite cell pool at normal levels [62]. 
Aging is accompanied by a decline in muscle mass and strength, a phenomenon referred as 
to sarcopenia [193]. It is clear that fitness is greater at any age in individuals who exercise 
regularly versus those who do not and that sarcopenia is reduced in physically active 
elderly people. A decline in the number of satellite cells, their proliferative capacities, or 
both, may contribute to sarcopenia. One of the mechanisms responsible for the reduced 
regenerative potential of old muscle seems to be the decline in Notch signaling [194]. Aging 
of skeletal muscle is characterized by an increase in fibrous connective tissue and adipose 
tissue and by an impairment of muscle regenerative potential [195,196]. This decrease of 
aged-muscle regeneration can be enhanced by direct activation of the Notch pathway [194] 
or by exposure to a youthful systemic environment [197]. Very interestingly, these age-
related effects are associated with increased canonical Wnt signaling in the satellite cell 
population, possibly resulting from increased amounts of Wnt or Wnt-like molecules in the 
serum of aged animals [24]. This generalized role of Wnt signaling in promoting an aging 
phenotype is consistent with the findings of Liu et al. [198]. 
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3.2.2. Non satellite cells 
Interestingly, a variety of non-satellite cell, located outside the basal lamina can also 
participate in skeletal muscle regeneration in the adult. These include pericytes, endothelial 
cells, mesoangioblasts [177,199,200,201,202], and interstitial cells (PICs) [203], as well as 
other cell types that are not fully characterized [26,204,205]. Polesskaya et al. found that a 
side population of cells harboring surface markers CD45 and Sca1 (CD45+:Sca1+) isolated 
from regenerating muscle readily underwent myogenic differentiation in vitro [26]. As 
quiescent satellite cells, activated satellite cells and satellite cell derived myoblasts do not 
express CD45 and satellite cell lineage do not express Sca1, CD45+:Sca1+ cells constitute a 
cellular pool distinct of muscle satellite cells. The fact that (i) activation of the canonical Wnt 
pathway by LiCl in isolated CD45+:Sca1+ cells was sufficient to induce muscle specification, 
(ii) myogenic commitment of CD45+:Sca1+ cells were induced by co-culture with cells 
ectopically expressing Wnt proteins and, (iii) the number of CD45+:Sca1+ cells was 
decreased in injured muscle treated with sFRPs, demonstrated clearly a functional 
requirement for canonical Wnt in the myogenic specification of CD45+:Sca1+ cells. These 
exciting results establish that myogenic progenitors derived from non-satellite cell can have 
a physiological role in muscle regeneration. 
3.2.3. Wnt-related regulation of myoblast proliferation and differentiation 
In addition to the crucial role of Wnt proteins in satellite cells fate and maintenance, they play 
an essential role in the control of proliferation and differentiation in various cellular types.  
In order to better characterize the role of Wnt proteins in the control of muscle cell 
differentiation, Bernardi et al. established Wnt expression pattern on C2C12 myoblasts and 
satellite cells [37]. They found that, among the 19 existing Wnts, only the expression of Wnt4 
was strongly activated from the early steps of differentiation. Interestingly, by modulating 
Wnt4 expression level with overexpression or silencing approaches, they reported a strong 
differentiation promoting activity of this factor (Figure 3). The relative increase in myotube 
size being comparable 48, 72, and 96 h after switching to differentiation medium indicates 
that Wnt4 signaling controls myotube size at the early steps of differentiation during 
myotube formation. The lack of Wnt4-mediated hypertrophic effect observed when cells 
were transfected the day of differentiation or later indicates that this factor has to be 
expressed during the proliferative stage to be effective. 
Fusion consists of two distinct phases: myoblast/myoblast fusion to form nascent myotubes 
and subsequent myoblast/myotubes fusion, resulting in a rapid accretion of size. The 
efficiency of the first phase can be evaluated by measuring the fusion index, which 
represents the proportion of the total cell population that has fused. After being switched to 
differentiation medium, Wnt4 overexpression in C2C12 and satellite cells gave a 62% and a 
67% fusion index increase, respectively, suggesting that Wnt4 signaling control nascent 
myotube formation. Recently, Tanaka et al. confirms that Wnt4 overexpression increased 
troponin-T positive cells in proliferation medium and enhanced myotube formation of 
differentiated C2C12 cells [206]. 
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Takata et al. reported that Wnt4 exhibited a low but significant myogenic activity with an 
increase of proliferation rate in myoblast cells [60]. Conversely, Otto and co-workers found, 
using co-culture of Wnt4-producing NIH-3T3 cell line on single muscle fiber culture, a 24% 
reduction of satellite-cell proliferation [207]. These conflicting results could be attributed 
either to the different specificities of the cellular models used or to the fact that effective 
concentration and physiological activity of ectopicWnt4 can be eminently variable, 
depending on the nature and activity of produced Wnt4. Taken together, these data are in 
agreement with a modest effect of Wnt4 on proliferation, suggesting a role of this factor in 
enhancing cell fusion rather than controlling the number of nuclei available for fusion. 
Knockdown of Wnt4 expression in C2C12 and satellite cells inhibits their differentiation and 
further confirms that Wnt4 acts as an effector of myogenesis (Figure 3). However, addition 
of siWnt4 after switching to differentiation medium or 24 h before did not decrease 
significantly the differentiation rate. This confirms that Wnt4 acts as a positive regulator of 
myogenic differentiation only if it is expressed in the proliferative phase. 
 
From Bernardi et al. Am J Physiol Cell Physiol-2011 
Figure 3. Effects of Wnt4 overexpression and Wnt4 silencing on C2C12 myoblasts and satellite cells 
differentiation. Stably transfected polyclonal C2C12 myoblasts with empty (Ctrl) or Wnt4-containing 
(Wnt4) expression vector were grown 2 days in proliferation medium followed by 4 days in 
differentiation medium. C2C12 myoblasts and satellite cells transfected with siRNA specific to Wnt4 
(siWnt4) and negative control siLuc were grown 2 days in proliferation medium followed by 4 days in 
differentiation medium. Fluorescent images of C2C12 myoblasts were obtained by immunostaining 
with a monoclonal anti-myosin antibody. Nuclei were labeled by DAPI staining. 
Myoblastic differentiation involves two major steps, their reversible withdrawal from cell 
cycle and the subsequent expression and activation of myogenic factors. Myf5 and MyoD 
are expressed in early myogenesis. As cells progress toward a differentiated phenotype, 
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myogenin and MRF4 are induced and cooperatively establish the irreversible commitment 
to terminal differentiation. Myf5 is a factor reported to be high in the Go phase, where cells 
were arrested to differentiate [208]. Borello et al. have previously showed a direct regulation 
of Myf5 expression by canonical Wnt signaling during somitogenesis [2]. Bernardi et al. 
found that the expression of Myf5 was activated by Wnt4 overexpression and strongly 
inhibited by Wnt4 silencing during C2C12 myoblast and satellite cells differentiation, 
suggesting that myogenic activity of Wnt4 is related to an increase of Myf5 expression. 
These authors by measuring Tcf/LEF gene canonical reporter activity and axin2 expression 
(a protein induced by canonical Wnt pathway), in the presence or absence of canonical Wnt 
pathway stimulators (LiCl or BIO), reported canonical Wnt pathway activation by Wnt4. 
Although this factor was originally described as a non-canonical Wnt, it has also been 
implicated in the activation or inhibition of the canonical Wnt pathway 
[55,56,57,58,59,60,61]. Numerous reports showed that Wnt-related myogenic activity is 
mediated mainly through a stimulation of canonical signaling. Thus, Takata et al. found that 
myogenic activity of Wnt4 is linked to an increase of -catenin signaling [60]. Likewise, 
Armstrong et al. have reported that the expression of -catenin is necessary for 
physiological growth of skeletal muscle and that Wnt signaling pathway induces -catenin 
activation of growth-control genes during overload induced skeletal muscle hypertrophy 
[209,210]. By using C2C12 and satellite cells, Han et al. reported recently that activation of 
canonical pathway by R-spondin2, promote myogenic differentiation and hypertrophic 
myofiber formation [211]. When LiCl was added to the culture medium, the area of 
myotubes and index fusion were increased in both C2C12 and satellite cells, reaching values 
similar to those observed after Wnt4-induced hypertrophy [37]. On the other hand, the fact 
that LiCl exerts a higher Tcf/LEF activation than Wnt4 treatment, whereas the extent of 
differentiation is the same suggests that this process is dependent on other signaling 
pathways. In this respect, work of Otto et al. (61) on isolated muscle fibers showed that 
Wnt4 inhibited satellite cell proliferation but that canonical Wnts such as Wnt1, Wnt3a, and 
Wnt5a induced a greater degree of proliferation than control cells, confirming the 
implication of other pathways in Wnt4 signaling [207]. The stronger activity in terms of 
Tcf/LEF activation of LiCl compared with Wnt4 (+100% on C2C12 myoblasts, +250% on 
satellite cells) treatments could explain the discrepancy between proliferative activities of 
Wnt4 and LiCl. Indeed, as described above, Wnt4 shows a weak effect on mitogenicity, 
whereas 10 mM LiCl has a strong anti-proliferative activity (-15% on satellite cells, -48% on 
satellite cells), suggesting that low levels of Tcf/LEF activation regulate myogenic 
differentiation, whereas higher levels regulate preferentially the proliferation. A study 
reported by Anakwe et al. is also in agreement with a relation between the level of Tcf/LEF 
activity and the type of cellular response elicited [209]. They reported an increase in the 
number of terminally differentiated cells in Wnt4 transfected myogenic cells, whereas the 
overexpression of canonical Wnt3a decreases the number of terminally differentiated 
myogenic cells. Making more complex the Wnt4-related signaling in muscle, Tanaka et al. 
showed very recently that Wnt4 promotes myogenesis and suppresses canonical Wnt 
signaling, culture conditions and C2C12 myoblasts characteristics may be at the origin of 
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this discrepancy and suggest that data emanating from established cell lines should be 
considered with care [206]. Moreover, the analysis of cellular response during myoblast 
differentiation can be made more complex by the implication of other signaling pathways 
like the non-canonical Wnt/calcium signaling. 
Recently, an elegant work from Rudnicki's group showed that Wnt signaling is also 
implicated in the control of muscular hypertrophy [27]. Skeletal muscle mass depends upon 
a dynamic balance between anabolic and catabolic processes. Muscle hypertrophy is 
characterized by an increase of the diameter of muscle fibers and increased protein synthesis, 
mainly by activation of the IGF1/Akt/mTORC1 pathway. They observed that Wnt7a binding 
to Fzd7 receptor directly activates the Akt/mTOR growth pathway, thereby inducing 
myofiber hypertrophy. Besides, they found that anabolic activity of Wnt7a is related to the 
activation of a new non-canonical pathway implicating stimulatory G protein, Gαs. 
3.2.4. Relation between Wnt4 and Myostatin  
Myostatin acts through the receptor-associated proteins Smad2 and Smad3 [33,212,213]. 
Phosphorylated Smad2 and Smad3 form heterodimeric complex with the common mediator 
Smad4. These activated Smad proteins function as the key intracellular mediators of 
signaling for myostatin as they translocate into the nucleus, and activate the transcription of 
the target genes through interaction with DNA and other nuclear factors [214,215]. Takata et 
al. reported that Wnt4 had no effect on Smad2 phosphorylation, but it antagonized Smad2 
phosphorylation induced by Mstn in differentiated C2C12 myoblasts [60]. They suggest that 
Wnt4 exert its myogenic effect by acting against Mstn. By using CAGA reporter assay, 
Bernardi et al. confirmed the inhibition of Mstn-activated Smad signaling pathway by Wnt4 
[37]. Contrary to differentiated myoblasts, Wnt4 decreased the CAGA reporter activity in 
proliferating myoblasts below the basal level meaning that Wnt4 has a stronger anti-Mstn 
activity during proliferation than during differentiation. Furthermore, the fact that the 
addition of Mstn did not reverse the Wnt4-induced CAGA reporter inhibition in myoblasts 
and satellite cells suggests that Mstn acts upstream of Wnt4 or that Wnt4 regulates the 
Mstn/Smad pathway independently of Mstn. The inhibition of the Mstn pathway by Wnt4 
can be associated with the inhibition of Mstn expression and/or inhibition of the Mstn/Smad 
transduction pathway. By using sqRT-PCR and promoter reporter experiments, authors 
showed that Wnt4 acted as an inhibitor of Mstn expression. Moreover, study with LiCl, 
strongly suggests that Wnt4 regulates negatively Mstn expression through activation of the 
canonical -catenin pathway. However, while Wnt4 down-regulates Mstn expression in 
proliferative and differentiated cells, the activation of canonical signaling by LiCl inhibits 
Mstn expression only when cells are in proliferative or early differentiated states. Thus, in 
function of the differentiation state, various signaling pathways can be implicated in the 
inhibition of Mstn expression by Wnt4 in myogenic cells. A biphasic mode of action of Wnt4 
can be proposed: in proliferative and early differentiated stages, Wnt4 acts by inducing 
canonical signaling, and later in the differentiation, canonical pathways is relaxed and 
another pathway maintains Mstn at low level. However, the fact that Wnt4 displayed the 
strongest CAGA reporter inhibiting activity in proliferative myoblasts, whereas Wnt4 had 
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the strongest Mstn expression inhibiting activity in differentiated myoblasts, implies that 
Wnt4 regulates both Mstn expression and Mstn/Smad signaling pathway. In silico analysis 
in the Mstn promoter revealed the presence of three putative Tcf/LEF binding sites within a 
2-kb sequence upstream of the Mstn gene at position -1889, -1028, and -743 confirming the 
observed regulation of the Mstn expression by Wnt/-catenin pathway. Analyze of 
reciprocal regulation of the both signaling pathways showed that whereas Mstn inhibits the 
accumulation of nuclear -catenin in differentiated C2C12 [36], Mstn was not able to inhibit 
Tcf/LEF activity induced by Wnt4 overexpression in proliferative and differentiated C2C12 
myoblasts [37]. Thus, contrary to adipogenic differentiation of human bone marrow-derived 
mesenchymal stem cells in which there is a cross-communication of the Mstn signal with 
Wnt/-catenin pathway, Wnt4/-catenin signaling pathway is not affected by Mstn. 
Mstn has been described as an inhibitor of myotube formation in C2C12 and satellite cells 
[32,33,34,35]. The reversion of Wnt4 activity by recombinant Mstn and the absence of 
hypertrophic activity of this factor in Mstn-/- mice demonstrated clearly that Wnt4 requires 
the presence of Mstn to elicit its differentiation promoting activity [37]. Thus the negative 
regulation of Mstn by Wnt4 is a crucial step for the myotube formation and hypertrophy. 
The fact that the addition of Mstn reverses the hypertrophic activity of Wnt4 but does not 
reverse the Wnt4-induced CAGA reporter inhibition implies that 1) Wnt4 acts upstream of 
Mstn and that 2) Wnt4 inhibits CAGA reporter by another pathway than Mstn/Smad 
signaling. Furthermore, the demonstration that Wnt4 can dominantly overcome the 
expression and activity of atrophic Mstn opens possibilities of the manipulation of Wnt4 or 
-catenin levels as a likely target for therapeutic design. 
4. Conclusion 
Development, growth and maintenance of muscle mass are critical for long-term health and 
quality of life. In this regard, activation of satellite cells and regulation of anabolic/catabolic 
muscular pathways play key roles. Production of new myofibrils and degradation of 
existing proteins is a delicate equilibrium, which, depending on the condition, can promote 
muscle growth or loss. In this matter, skeletal muscle has the capacity to continuously 
regulate its size in response to a variety of external cues and serves as the most significant 
repository for protein in the body of healthy adult humans (~50% total protein content). To 
achieve a correct development and to maintain homeostasis, the biological response of the 
skeletal muscle implies a multitude of regulatory signaling pathways that orchestrates 
myogenesis in embryonic development and enables adult muscle repair. There is much 
interest in understanding the cellular and molecular mechanisms underlying skeletal muscle 
homeostasis and regeneration in different contexts because such knowledge might help in 
the development of cell therapies for diseases characterized by skeletal muscle degeneration. 
As described in this review, it is clear that Wnt play multiple and essential actions both in 
developmental and postnatal muscles. Depending not only of the Wnt signaling pathways 
implicated but also of the other interacting signaling pathways, Wnt proteins can act to 
promote or inhibit myogenesis. Further study will be necessary to elucidate the complex 
network that regulates embryonic and adult myogenesis. 
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